Capital Research & Management Co recently announced the acquisition of new stake in Halliburton Co. (NYSE:HAL). The institutional investor has increased its shareholding in the Energy company by 5.82% to 121.07 million shares with purchase of 6.66 million shares. This fresh investment now brings its stake to 13.53% valued currently at $4.38 billion. In addition, SSgA Funds Management, Inc. raised its holdings by 0.38 million to 57.58 million shares. And T. Rowe Price Associates, Inc. has lifted its position by 449.55% or 28.59 million shares – to 34.96 million shares.
Currently, there are 902.00M common shares owned by the public and among those 891.56M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 48 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 1,105,058 shares. Insider sales of the common stock occurred on 29 occasions, with total insider shares sold totaling 975,394 shares.
The top 3 mutual fund holders in Halliburton Co. are American Balanced Fund, Washington Mutual Investors Fund, and Vanguard Total Stock Market ETF. American Balanced Fund owns 39.41 million shares of the company’s stock, all valued at over $1.42 billion. Washington Mutual Investors Fund bought 0.23 million shares to see its total holdings expand to 33.2 million shares valued at over $1.2 billion and representing 3.71% of the shares outstanding. Vanguard Total Stock Market ETF sold 10349.0 shares to bring its total holdings to over 25.32 million shares at a value of $915.49 million. Vanguard Total Stock Market ETF now owns shares totaling to 2.83% of the shares outstanding.
However, the script later moved the day high at 37.86, up 1.43%. The company’s stock has a 5-day price change of 10.48% and -7.06% over the past three months. HAL shares are trading 3.82% year to date (YTD), with the 12-month market performance down to -6.25% lower. It has a 12-month low price of $27.84 and touched a high of $43.85 over the same period. HAL has an average intraday trading volume of 6.95 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.69%, 3.80%, and 3.15% respectively.
Institutional ownership of Halliburton Co. (NYSE: HAL) shares accounts for 86.86% of the company’s 902.00M shares outstanding. Mutual fund holders own 56.07%, while other institutional holders and individual stakeholders account for 7.50% and 31.40% respectively.
It has a market capitalization of $33.59B and a beta (3y monthly) value of 2.02. The stock’s trailing 12-month PE ratio is 12.82, while the earnings-per-share (ttm) stands at $2.93. The company has a PEG of 0.88 and a Quick Ratio of 1.48 with the debt-to-equity ratio at 0.94. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.67% over the week and 2.52% over the month.
Analysts forecast that Halliburton Co. (HAL) will achieve an EPS of $0.69 for the current quarter, $0.75 for the next quarter and $3.63 for 2025. The lowest estimate earnings-per-share for the quarter is $0.67 while analysts give the company a high EPS estimate of $0.74. Comparatively, EPS for the current quarter was $0.72 a year ago. Earnings per share for the fiscal year are expected to increase by 9.20%, and 15.97% over the next financial year. EPS should grow at an annualized rate of 14.60% over the next five years, compared to 9.11% over the past 5-year period.
Looking at the support for the HAL, a number of firms have released research notes about the stock. TD Cowen stated their Outperform rating for the stock in a research note on January 24, 2024, with the firm’s price target at $49-$51.
